Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;10(5):OC01-4.
doi: 10.7860/JCDR/2016/17631.7713. Epub 2016 May 1.

Comparison of Hypnotherapy and Standard Medical Treatment Alone on Quality of Life in Patients with Irritable Bowel Syndrome: A Randomized Control Trial

Korosh Shahbazi  1 , Kamal Solati  2 , Ali Hasanpour-Dehkordi  3
Affiliations

Comparison of Hypnotherapy and Standard Medical Treatment Alone on Quality of Life in Patients with Irritable Bowel Syndrome: A Randomized Control Trial

Korosh Shahbazi et al. J Clin Diagn Res. 2016 May.

Abstract

Introduction: Irritable bowel syndrome (IBS) is one of the most prevalent gastroenterological disorders. IBS is characterized by abdominal pain, cramping, diarrhea, constipation, bloating and flatulence. Complementary therapy is a group of diverse therapeutic and health care systems products that are used in treatment of IBS. Hypnotherapy helps to alleviate the symptoms of a broad range of diseases and conditions. It can be used independently or along with other treatments.

Aim: This study was conducted to compare therapeutic effect of hypnotherapy plus standard medical treatment and standard medical treatment alone on quality of life in patients with IBS.

Materials and methods: This study is a clinical trial investigating 60 patients who were enrolled according to Rome-III criteria. The sample size was determined per statistical advice, previous studies, and the formula of sample size calculation. The participants were randomly assigned to two groups of hypnotherapy plus standard medical treatment group (n: 30), and standard medical treatment group (30). The study consisted of three steps; prior to treatment, after treatment and six months after the last intervention (follow-up). The instruments of data gathering were a questionnaire of demographic characteristics and standard questionnaire of quality of life for IBS patients (Quality of Life IBS-34). The data were analysed by analysis of co-variance, Levene's test and descriptive statistics in SPSS-18.

Results: There were significant differences between the two groups of study in post-treatment and follow-up stage with regards to quality of life (p<0.05).

Conclusion: Psychological intervention, particularly hypno-therapy, alongside standard medical therapy could contribute to improving quality of life, pain and fatigue, and psychological disorder in IBS patients resistant to treatment. Also, therapeutic costs, hospital stay and days lost from work could be decreased and patients' efficiency could be increased.

Keywords: Complementary medicine; Inflammatory bowel disease(HBD); Quality of life.

PubMed Disclaimer

References

    1. Sorouri M, Pourhoseingholi MA, Vahedi M, Safaee A, Moghimi-Dehkordi B, Pourhoseingholi A, et al. Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol. 2010;16(3):154–60. - PMC - PubMed
    1. Ashtari S, Sorouri M, Moghimi-Dehkordi B, Pourhoseingholi MA, Safaee A, Vahedi M, et al. Prevalence of Functional Bowel Disorders in Tehran Province. Popul J Knowl Health. 2011;6(3):31–39.
    1. Chey WD, Lembo AJ, Lavins BJ, Shiff SJ, Kurtz CB, Currie MG, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol. 2012;107(11):1702–12. - PubMed
    1. Wilson D, Hungin A, Howse J, De Meester F, Singh R, Wilczynska A, et al. Role of hormones and neuropeptides in IBS and other gastrointestinal disorders: understanding variability and chrononutrition. Open Nutr J. 2011;4:213–25.
    1. Dehkordi A, Heydarnejad MS, Fatehi D. Quality of life in cancer patients undergoing chemotherapy. Oman Med J. 2009;24(3):204. - PMC - PubMed

LinkOut - more resources